Riyadh

As the flagship city for Saudi Vision 2030, Riyadh has rapidly evolved into a premier global life sciences hub, anchoring the Middle East’s most ambitious healthcare and biotechnology initiatives.

The capital is best known for its National Biotechnology Strategy, which focuses on localizing vaccine and biopharmaceutical production to ensure regional health security.

Riyadh hosts a dense concentration of pharmaceutical manufacturing giants, including SPIMACO and Riyadh Pharma, alongside global leaders like Pfizer and GlaxoSmithKline that leverage the city’s advanced regulatory environment.

The city is a pioneer in digital health, home to the SEHA Virtual Hospital and cutting-edge genomics and precision medicine programs.

Academic research in Riyadh is propelled by world-class institutions such as King Faisal Specialist Hospital & Research Centre (KFSHRC) and KAIMRC, which lead the region in clinical trials and stem cell therapy.

The city’s medical device sector is also surging, supported by a robust infrastructure for 3D printing and specialized diagnostic technologies.

To further solidify its status, Riyadh serves as the permanent host for BIO Middle East and CPHI Middle East, connecting global investors with local biotech startups.

Foreign investors and life sciences professionals are increasingly drawn to the city's specialized biotech parks and the lucrative incentives provided by the Saudi government for R&D collaboration.

Ultimately, Riyadh is redefining the life sciences ecosystem by integrating artificial intelligence into drug discovery and fostering a sustainable, innovation-driven economy.